hsTnT After Elective Coronary Angiography
This study has been completed.
Information provided by (Responsible Party):
Haitham Abu Sharar, University Hospital Heidelberg
First received: November 24, 2012
Last updated: November 27, 2012
Last verified: November 2012
A prospective Study, aiming to understand and analyse the key role of the novel High Sensitivity Troponin T (hsTnT) within a group of patients undergoing an uncomplicated coronary angiography without receiving any additional intervention. The peri-procedural elevation of the hsTnT indicates some other factors being responsible for the elevation of the hsTnT in absence of an acute coronary syndrome, such as physiological components or micro-injuries. A one year follow-up has been collected.
||Observational Model: Cohort
Time Perspective: Prospective
||Rise of hscTnT After Elective Coronary Angiography Without Coronary Intervention
Primary Outcome Measures:
- Cardiovascular mortality [ Time Frame: Up to 12 months after procedure ] [ Designated as safety issue: No ]
| Study Start Date:
| Primary Completion Date:
||November 2011 (Final data collection date for primary outcome measure)
CAG without PCI
CAG with PCI
|Ages Eligible for Study:
||18 Years and older
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
Consecutive patients with stable or unknown CAD undergoing CAG with/or without PCI. Patients receiving additional examination, such as biopsy, Ablation or any other procedure that could lead to myocardial injury resulting in elevation of the cardiac Troponin are being excluded, as well as Patients with acute coronary syndrome.
- Stable or unknown CAD
- Acute Coronary Syndrome
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01735500
|Department of Cardiology - University Hospital of Heidelberg
|Heidelberg, Germany, 69120 |
University Hospital Heidelberg
||Evangelos Giannitsis, Prof. Dr. med.
||Department of Cardiology, University Hospital of Heidelberg
No publications provided
||Haitham Abu Sharar, Physician, University Hospital Heidelberg
History of Changes
|Other Study ID Numbers:
||hsTnT Elective CAG
|Study First Received:
||November 24, 2012
||November 27, 2012
||Germany: University Hospital Heidelberg
Keywords provided by University Hospital Heidelberg:
cardia Troponin T
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on November 24, 2014
Coronary Artery Disease
Arterial Occlusive Diseases